Introduction
============

Confocal laser endomicroscopy (CLE) is a novel endoscopic imaging technique that provides in vivo histology during ongoing endoscopy. Two CLE systems have been developed for the gastrointestinal tract: an endoscope-integrated system and a probe-based system; however, the endoscope-integrated system is inaccessible deep within the small bowel and is no longer commercially available. The probe-based system was developed by Mauna Kea Technologies (Cellvizio; Mauna Kea Technologies, Paris, France) [@JR685-1] . This miniprobe can be introduced through the working channel of any endoscope to visualize the tissue at a microscopic level at the same time as the macroscopic imaging [@JR685-2] . Furthermore, the GastroFlex UHD and Coloflex UHD probes are 3 m and 4 m long, respectively, and therefore they can be used during balloon-assisted enteroscopy. To our knowledge, little is known about the application of CLE in small-bowel diseases [@JR685-3] . These miniprobes provide a resolution of up to 1 µm after the administration of fluorescent contrast, depth of focus between 55 and 65 µm, and a fast video-rate scanning of 12 images per second. CLE may enable more live images than conventional pathology.

In this study, we determined the roles of probe-based CLE (pCLE) during double-balloon enteroscopy (DBE) for the detection of abnormalities and the diagnosis of various small-bowel diseases.

Methods
=======

Study design
------------

This was a retrospective single-center observational open-label pilot study. We measured the calibers of capillary and lymphatic vessels between pCLE images and histopathology, and determined the vessel characteristics in various small-bowel diseases. Next, we retrospectively compared the pCLE findings with pathological findings, and determined their concordance rate. This study was reviewed and approved by the Institutional Review Board of Fujita University School of Medicine. This study was registered with the University Hospital Medical Information Network (UMIN 000013857).

Double-balloon enteroscopy and probe-based confocal laser endomicroscopy
------------------------------------------------------------------------

DBE (Fujifilm Corporation, Tokyo, Japan) was performed as described previously [@JR685-4] [@JR685-5] . pCLE examinations were performed with a Coloflex UHD or a Gastroflex UHD probe through the working channel (2.8 mm or 3.2 mm diameter) of an enteroscope (EN-450 T or 580 T) after intravenous injection of 250 -- 500 mg fluorescein (100 mg/mL, Fluorescite, Alcon Japan Ltd., Tokyo, Japan).

Measurement of the capillary and lymphatic vessel calibers and interpretation of other images
---------------------------------------------------------------------------------------------

Fluorescein-enhanced capillary vessels were classified into two types: capillary vessels beneath the epithelial cells and in the middle of the villi. The calibers of these two vessels at five different sites were estimated at three locations on one capillary vessel in one image with "measure object dimension" software in the Cellvizio viewer (Mauna Kea Technologies). In brief, the reader placed a cursor at one end of the fluorescein-enhanced vessel and then moved the cursor to the other end of the shortest dimension at right angles to the duct axis, which indicated the intraluminal diameter of the vessel. If the caliber varied in diameter, the reader measured both the shortest and longest diameters ( [Fig. 1a](#FI685-1){ref-type="fig"} ). Lymphatic vessels were designated as a reticular network of unenhanced dark branching bands, and their calibers were estimated as above ( [Fig. 1b](#FI685-1){ref-type="fig"} ). Other image interpretations included cell gap, erosion, fluorescence enhancement of lamina propria, and dark tumor cells.

![ Measurement of the inner diameters of the capillary and lymphatic vessels (Patient \#30: intestinal lymphangiectasia in the ileum). **a** Probe-based confocal laser endomicroscopic image of the capillary vessels. **b** Immunohistochemical staining with CD34 antibodies in a biopsy specimen with a magnification of × 400. **c** Probe-based confocal laser endomicroscopic image of lymphatic vessels. **d** Immunohistochemical staining with D2-40 antibodies in a biopsy specimen with a magnification of × 200.](10-1055-s-0043-106184-i685ei1){#FI685-1}

Histologic analysis and comparison of the inner diameters of capillary vessels between pCLE and histology
---------------------------------------------------------------------------------------------------------

Biopsy specimens from DBE were fixed with 10 % neutral buffered formalin, and paraffin-embedded sections were reviewed histologically by pathologists who were blinded to this study. Specific pathologic findings included dilated lymphatic lacteals in the lamina propria that were immunopositive with a monoclonal antibody against D2-40 (Dako, Tokyo, Japan) in intestinal lymphangiectasia; lymphoma cells that were immunopositive with monoclonal antibodies against CD20, CD10, bcl-2, and cyclinD1 (Dako), and crypt hyperplasia that was immunopositive with a monoclonal antibody Ki-67 (Dako) in villous atrophy.

In patients with dilated lymphatic lacteals that could be observed with pCLE, bioptic specimens were immunostained with monoclonal antibodies against CD34 (Dako) and D2-40. The calibers of capillary vessels positive with CD34 at three different sites and lymphatic vessels positive with D2-40 at two different sites were measured with a point-to-point distance measuring function (Provis AX-80 optical microscope and DP20 digital camera, Olympus Corporation, Tokyo, Japan) and then were compared with those in the pCLE images.

Statistical analysis
--------------------

The values presented in the text are expressed as means ± standard deviation. Comparisons between lesions (n = 15 in each patient) and normal controls (n = 60 in four controls) were analyzed using the Mann-Whitney *U* test. Comparisons of the calibers of capillary vessels positive with CD34 and lymphatic vessels positive with D2-40 between immunostained bioptic specimens and pCLE images were analyzed using the Mann-Whitney *U* test. Differences were considered statistically significant for *P* values less than 0.05.

Results
=======

Patients
--------

In total, 130 patients were admitted to Fujita Health University Hospital to undergo DBE between April 2014 and January 2016. Informed consent was obtained from 37 patients who underwent probe-based confocal laser endomicroscopy (pCLE, Cellvizio; Mauna Kea Technologies, Paris, France) during DBE. The 37 patients underwent a total of 38 DBE and pCLE examinations; 24 via the oral route and 14 via the anal route using Coloflex UHD (n = 16) and Gastroflex UHD (n = 22) probes. Patient \#2 with follicular lymphoma underwent a second anal DBE examination 16 months after the first anal DBE examination, and rituximab monotherapy. Patient \#29 had villous atrophy and crypt apoptosis throughout the small intestine, and a few CD3-positive intraepithelial lymphocytes (5 -- 10/100 epithelial cells). She was negative with anti-gliadin, anti-tissue transglutaminase, or anti-endomysial antibody. At colonoscopy, there were only several erosions in the rectum, but pathologically accompanied by a 25 µm thick subepithelial collagen band. Her symptoms recovered and endoscopic findings improved with discontinuation of clonazepam, not with a gluten-free diet. Therefore, we diagnosed her as having clonazepam-induced intestinal injury.

Double-balloon enteroscopy was often in a torqued position, when advancing the probe through the working channel was difficult. In this case, we first put the top-down and/or left-right angle knobs to the neutral position. If impossible, we then withdrew the scope a little to loosen the scope angle. Clinical characteristics are presented in   [Table 1](#TB685-1){ref-type="table"} . The median number (range) of biopsy specimens at DBE in 31 patients was 4 (2 -- 10). One polypectomy specimen, one endoscopic mucosal resection specimen, and one surgical specimen were taken from Patients \#10, \#11, and \#33, respectively. All authors had access to the study data, and reviewed and approved the final manuscript.

###### Clinical features in 37 patients who underwent probe-based confocal laser endomicroscopy during double-balloon enteroscopy.

  **Patient number**               **Final diagnosis**                                                               **Sex**   **Age, years**   **DBE route**   **Location of the lesions examined**   **Indications**
  -------------------------------- --------------------------------------------------------------------------------- --------- ---------------- --------------- -------------------------------------- --------------------------------------------------------
  **Small-bowel tumors/polyps**                                                                                                                                                                        
   1                               Malignant lymphoma (mantle cell lymphoma)                                         M         82               Oral            Jejunum                                Asymptomatic (Check-up)
   2                               Malignant lymphoma (follicular lymphoma)                                          F         65               Anal            Ileum                                  Occult small-bowel bleeding
   3                               Malignant lymphoma (follicular lymphoma)                                          F         56               Anal            Ileum                                  Asymptomatic (Check-up)
   4                               Malignant lymphoma (DLBCL transformed from follicular lymphoma)                   F         57               Oral            Jejunum                                Abdominal pain
   5                               Malignant lymphoma (DLBCL transformed from follicular lymphoma)                   F         55               Anal            Ileum                                  Diarrhea
   6                               Malignant lymphoma (DLBCL)                                                        M         78               Anal            Ileum                                  Occult small-bowel bleeding
   7                               Malignant lymphoma (Burkitt lymphoma) [1](#FN685-2){ref-type="table-fn"}          F         66               Oral            Jejunum                                Small-bowel obstruction
   8                               Adenocarcinoma at an advanced stage                                               M         41               Oral            Jejunum                                Small-bowel obstruction
   9                               Metastasis from cervical cancer                                                   F         62               Oral            Ligament of Treitz                     Small-bowel obstruction
  10                               Peutz-Jeghers syndrome                                                            F         52               Oral            Jejunum                                Asymptomatic (Follow-up)
  **Vascular diseases**                                                                                                                                                                                
  11                               Hereditary hemorrhagic telangiectasia                                             M         73               Anal            Ileum                                  Occult small-bowel bleeding
  12                               Angiodysplasia                                                                    F         74               Oral            Jejunum                                Occult small-bowel bleeding
  13                               IgA vasculitis                                                                    M         70               Oral            Jejunum                                Overt small-bowel bleeding and abdominal pain
  14                               Eosinophilic granulomatosis with polyangiitis                                     M         55               Anal            Ileum                                  Diarrhea
  15                               Ischemic stricturing enteritis                                                    F         80               Anal            Ileum                                  Overt small-bowel bleeding and small-bowel obstruction
  16                               Ischemic stricturing enteritis                                                    F         64               Oral            Jejunum                                Small-bowel obstruction
  **Inflammatory diseases**                                                                                                                                                                            
  17                               Crohn's disease                                                                   M         22               Oral            Jejunum                                Small-bowel obstruction
  18                               Crohn's disease                                                                   F         51               Oral            Ileum                                  Small-bowel obstruction
  19                               Crohn's disease                                                                   M         31               Anal            Ileum                                  Small-bowel obstruction
  20                               Chronic non-specific multiple ulcers unrelated to NSAIDs                          F         55               Oral            Ileum                                  Small-bowel obstruction
  21                               Chronic non-specific multiple ulcers unrelated to NSAIDs                          F         39               Oral            Ileum                                  Small-bowel obstruction
  22                               Chronic non-specific multiple ulcers unrelated to NSAIDs                          F         48               Oral            Jejunum                                Occult small-bowel bleeding
  23                               Chronic non-specific multiple ulcers unrelated to NSAIDs                          F         42               Oral            Jejunum                                Protein-losing enteropathy
  24                               Chronic non-specific multiple ulcers unrelated to NSAIDs                          F         39               Anal            Ileum                                  Protein-losing enteropathy
  25                               Hypogammaglobulinemia-associated atrophic enteritis with malabsorption syndrome   M         50               Oral            Jejunum                                Diarrhea
  **Iatrogenic diseases**                                                                                                                                                                              
  26                               Aspirin-induced small-intestinal injury                                           F         73               Anal            Ileum                                  Occult small-bowel bleeding
  27                               Diclofenac-induced small-intestinal injury                                        M         53               Oral            Duodenum-jejunum                       Overt small-bowel bleeding
  28                               Loxoprofen-induced small-intestinal injury                                        F         88               Oral            Jejunum                                Small-bowel obstruction
  29                               Clonazepam-induced small-intestinal injury with protein-losing enteropathy        F         54               Oral            Jejunum                                Diarrhea
  **Other small-bowel diseases**                                                                                                                                                                       
  30                               Intestinal lymphangiectasia with protein-losing enteropathy                       F         42               Anal            Ileum                                  Protein-losing enteropathy
  31                               Intestinal lymphangiectasia with protein-losing enteropathy                       M         66               Oral            Jejunum                                Protein-losing enteropathy
  32                               Intestinal lymphangiectasia with protein-losing enteropathy                       M         71               Oral            Jejunum                                Protein-losing enteropathy
  33                               Meckel's diverticulum                                                             M         27               Anal            Ileum                                  Overt small-bowel bleeding
  **Normal small bowel**                                                                                                                                                                               
  34                               Colonic diverticular hemorrhage                                                   M         71               Oral            Jejunum                                Overt small-bowel bleeding
  35                               Suspected Crohn's disease                                                         M         26               Anal            Ileum                                  Right lower quadrant pain
  36                               Hypogammaglobulinemia                                                             M         36               Oral            Jejunum                                Occult small-bowel bleeding
  37                               Abdominal pain                                                                    M         36               Oral            Jejunum                                Abdominal pain

DBE, double-balloon enteroscopy; DLBCL, diffuse large B cell lymphoma; NSAID, nonsteroidal anti-inflammatory drug.

Complete remission by chemotherapy and complicated by cytomegalovirus infection-associated small-intestinal ulcers.

Measurement of the inner diameter of capillary vessels and capillary characteristics at pCLE
--------------------------------------------------------------------------------------------

The inner diameters of capillary vessels beneath the epithelium and in the middle of the villi are shown in   [Table 2](#TB685-2){ref-type="table"} . In four patients with an apparently normal small bowel with normal bioptic histology, the diameters of capillary vessels beneath the epithelium and in the middle of the villi (60 portions of capillary vessels each) were 16.2 ± 3.0 µm and 14.5 ± 3.1 µm, respectively ( *P*  = 0.0009). Comparison between four normal controls and the inner diameters of capillary vessels beneath the epithelium or in the middle of the villi is shown in   [Table 2](#TB685-2){ref-type="table"} .

###### Inner diameters of the capillary vessels at probe-based confocal laser endomicroscopy.

                                      **Inner diameters of the capillary vessels**                                                                                                         
  ----------------------------------- --------------------------------------------------------------------------------- ------------ ------------- ------------- ------------ ------------ ------------
  **Small-bowel tumors/polyps**                                                                                                                                                            
   1                                  Malignant lymphoma (mantle cell lymphoma)                                         13.6 ± 5.5   n.s.          12.9 ± 1.7    Smaller      0.0420       
   2                                  Malignant lymphoma (follicular lymphoma)                                          10.3 ± 2.2   Smaller        \< 0.0001    12.3 ± 4.1   Smaller      0.0279
   3                                  Malignant lymphoma (follicular lymphoma)                                          12.4 ± 2.4   Smaller        \< 0.0001    11.1 ± 4.4   Smaller      0.0055
   4                                  Malignant lymphoma (DLBCL transformed from follicular lymphoma)                   n.d.         23.7 ± 11.0   Larger        0.0004                    
   5                                  Malignant lymphoma (DLBCL transformed from follicular lymphoma)                   15.0 ± 3.2   n.s.          21.9 ± 6.9    Larger        \< 0.0001   
   6                                  Malignant lymphoma (DLBCL)                                                        13.7 ± 3.6   Smaller       0.0148        25.2 ± 8.0   Larger        \< 0.0001
   7                                  Malignant lymphoma (Burkitt lymphoma) [1](#FN685-2){ref-type="table-fn"}          18.3 ± 5.0   n.s.          24.6 ± 5.6    Larger        \< 0.0001   
   8                                  Adenocarcinoma at an advanced stage                                               n.d.         26.0 ± 10.1   Larger         \< 0.0001                
   9                                  Metastasis from cervical cancer                                                   17.4 ± 5.7   n.s.          31.0 ± 14.9   Larger        \< 0.0001   
  10                                  Peutz-Jeghers syndrome                                                            15.5 ± 3.8   n.s.          18.2 ± 4.6    Larger       0.0040       
  **Vascular diseases**                                                                                                                                                                    
  11                                  Hereditary hemorrhagic telangiectasia                                             17.3 ± 5.3   n.s.          26.0 ± 12.9   Larger        \< 0.0001   
  12                                  Angiodysplasia                                                                    21.7 ± 4.5   Larger         \< 0.0001    13.4 ± 9.7   n.s.         
  13                                  IgA vasculitis                                                                    12.3 ± 5.1   Smaller       0.0098        11.5 ± 3.1   Smaller      0.0040
  14                                  Eosinophilic granulomatosis with polyangiitis                                     15.2 ± 2.4   n.s.          15.9 ± 6.9    n.s.                      
  15                                  Ischemic stricturing enteritis                                                    19.3 ± 3.2   Larger        0.0007        18.1 ± 5.1   Larger       0.0165
  16                                  Ischemic stricturing enteritis                                                    16.1 ± 2.3   n.s.          24.0 ± 7.4    Larger        \< 0.0001   
  **Inflammatory diseases**                                                                                                                                                                
  17                                  Crohn's disease                                                                   13.3 ± 2.6   Smaller       0.0012        14.7 ± 2.9   n.s.         
  18                                  Crohn's disease                                                                   10.9 ± 2.1   Smaller        \< 0.0001    13.6 ± 4.2   n.s.         
  19                                  Crohn's disease                                                                   13.9 ± 2.7   Smaller       0.0078        16.1 ± 6.4   n.s.         
  20                                  Chronic non-specific multiple ulcers unrelated to NSAIDs                          15.8 ± 3.3   n.s.          16.8 ± 4.5    n.s.                      
  21                                  Chronic non-specific multiple ulcers unrelated to NSAIDs                          12.4 ± 4.9   Smaller       0.0024        14.7 ± 4.4   n.s.         
  22                                  Chronic non-specific multiple ulcers unrelated to NSAIDs                          13.1 ± 3.9   Smaller       0.0053        14.9 ± 5.8   n.s.         
  23                                  Chronic non-specific multiple ulcers unrelated to NSAIDs                          12.3 ± 2.9   Smaller        \< 0.0001    16.0 ± 5.3   n.s.         
  24                                  Chronic non-specific multiple ulcers unrelated to NSAIDs                          13.5 ± 2.6   Smaller       0.0020        13.3 ± 3.2   n.s.         
  25                                  Hypogammaglobulinemia-associated atrophic enteritis with malabsorption syndrome   10.9 ± 2.5   Smaller        \< 0.0001    14.0 ± 2.8   n.s.         
  **Iatrogenic diseases**                                                                                                                                                                  
  26                                  Aspirin-induced small-intestinal injury                                           17.1 ± 3.8   n.s.          13.4 ± 2.2    n.s.                      
  27                                  Diclofenac-induced small-intestinal injury                                        17.3 ± 3.1   n.s.          17.6 ± 4.5    Larger       0.0082       
  28                                  Loxoprofen-induced small-intestinal injury                                        12.7 ± 2.3   Smaller       0.0001        15.1 ± 4.6   n.s.         
  29                                  Clonazepam-induced small-intestinal injury with protein-losing enteropathy        15.0 ± 4.2   n.s.          17.4 ± 3.8    Larger       0.0100       
  **Other small-bowel diseases**                                                                                                                                                           
  30                                  Intestinal lymphangiectasia with protein-losing enteropathy                       14.0 ± 3.2   Smaller       0.0073        15.9 ± 4.0   n.s.         
  31                                  Intestinal lymphangiectasia with protein-losing enteropathy                       14.4 ± 5.1   Smaller       0.0168        19.8 ± 9.9   n.s.         
  32                                  Intestinal lymphangiectasia with protein-losing enteropathy                       17.4 ± 2.0   n.s.          20.1 ± 8.0    Larger       0.0075       
  33                                  Meckel's diverticulum                                                             16.6 ± 3.2   n.s.          19.8 ± 6.2    Larger       0.0011       
  **Normal small bowel (controls)**                                                                                                                                                        
  34                                  Colonic diverticular hemorrhage                                                   16.3 ± 1.6                 13.4 ± 1.7                              
  35                                  Suspected Crohn's disease                                                         13.0 ± 3.0                 12.8 ± 2.6                              
  36                                  Hypogammaglobulinemia                                                             17.7 ± 2.1                 16.5 ± 2.4                              
  37                                  Abdominal pain                                                                    17.8 ± 2.7                 15.1 ± 4.1                              

DLBCL, diffuse large B cell lymphoma; NSAID, nonsteroidal anti-inflammatory drug; SD, standard deviation; n.s., not significant; n.d., not detected.

Throughout mantle cell lymphoma and follicular lymphoma, or in follicles adjacent to circumferential ulcers of diffuse large B-cell lymphoma (DLBCL), a "soccer ball-like pattern" was characteristic, with homogenous dark cells suggesting that lymphoma cells (7 -- 10 µm in diameter in small-cell lymphoma and 10 -- 20 µm in diameter in large-cell lymphoma) were packed with polygonal, slightly narrow and stretched capillary vessels ( [Fig. 2a--d](#FI685-2){ref-type="fig"} and   [Fig. 3a, b](#FI685-3){ref-type="fig"} ). In lymphoid follicles with complete remission status, homogenous lymphoid-like cells were observed but not packed with those characteristic capillary vessels ( [Fig. 3c, d](#FI685-3){ref-type="fig"} ). In metastasis from cervical cancer, irregular dark nests suggesting metastatic squamous cell carcinoma were observed in the lamina propria, accompanied by markedly dilated capillary vessels suggesting tumor vessels ( [Fig. 4a--c](#FI685-4){ref-type="fig"} ). In a patient with hereditary hemorrhagic telangiectasia (HHT), dilated crooked capillary vessels were observed, and, notably, these vessels communicated with remarkably dilated vessels (30 -- 40 µm in diameter) in the middle of the villi, suggesting a micro-arteriovenous malformation ( [Fig. 5a--d](#FI685-5){ref-type="fig"} ). In a solitary angiodysplasia, various sizes of dilated proliferating capillary vessels appeared, anastomosing more frequently than normal (  [Fig. 5e, f](#FI685-5){ref-type="fig"} ). In IgA vasculitis (formerly Henoch-Shöenlein purpura), multiple stenosing capillary vessels, like "a string of sausages", were observed around the ulcers, which may lead to ischemic changes ( [Fig. 6a--c](#FI685-6){ref-type="fig"} ).

![ Mantle cell lymphoma (Patient \#1). **a** Enteroscopic view in the jejunum. **b** A probe-based confocal laser endomicroscopic image shows the homogenous cells packed with polygonal capillary vessels in a "soccer ball-like pattern. **c** H&E staining in a biopsy specimen with a magnification of × 200. **d** Immunohistochemical staining with CD20 antibodies in a biopsy specimen with a magnification of × 200.](10-1055-s-0043-106184-i685ei2){#FI685-2}

![ Follicular lymphoma (Patient \#2). **a** Enteroscopic view in the ileum before treatment. **b** A probe-based confocal laser endomicroscopic image shows the homogenous cells packed with polygonal capillary vessels in a "soccer ball-like pattern". **c** Enteroscopic view in the ileum after rituximab monotherapy. Slightly reddish follicles are observed. **d** A probe-based confocal laser endomicroscopic image does not show a "soccer ball-like pattern" after rituximab monotherapy.](10-1055-s-0043-106184-i685ei3){#FI685-3}

![ Metastasis from cervical cancer (Patient \#9). **a** Chromoenteroscopic view with indigo carmine after intravascular administration of fluorescein in the ligament of Treitz. **b** A probe-based confocal laser endomicroscopic image shows dark irregular tumor nests accompanied by dilated tortuous capillary vessels. **c** H&E staining in a biopsy specimen with a magnification of × 100. **d** H&E staining in a biopsy specimen with a magnification of × 400.](10-1055-s-0043-106184-i685ei4){#FI685-4}

![ Arteriovenous malformation. **a** Enteroscopic view of hereditary hemorrhagic telangiectasia in the ileum (Patient \#11). **b** A probe-based confocal laser endomicroscopic image shows a micro-arteriovenous malformation. **c** H&E staining in an endoscopic mucosal resection specimen observed in **a** and **b** with a magnification of × 200. **d** H&E staining in an endoscopic mucosal resection specimen observed in **a** and **b** with a magnification of × 400. **e** Enteroscopic view of a solitary angiodysplasia in the jejunum (Patient \#12). **f** A probe-based confocal laser endomicroscopic image shows a micro-arteriovenous malformation.](10-1055-s-0043-106184-i685ei5){#FI685-5}

![ IgA vasculitis (Patient \#13). **a** Enteroscopic view in the jejunum. **b** A probe-based confocal laser endomicroscopic image. Arrows indicate segmental strictures of a capillary vessel, similar to "a string of sausages". **c** H&E staining in a biopsy specimen shows leukocytoclastic vasculitis with a magnification of × 400.](10-1055-s-0043-106184-i685ei6){#FI685-6}

Measurement of the inner diameter of lymphatic vessels and lymphatic characteristics with pCLE
----------------------------------------------------------------------------------------------

Lymphatic vessels were observed in only five patients (17 %). In non-white type intestinal lymphangiectasias (Patients \#24 and \#26), CNSU (Patients \#16 and \#18), and metastasis from cervical cancer (Patient \#5), their inner diameters were 8.1 ± 1.5 µm, 5.2 ± 1.3 µm, 4.8 ± 1.0 µm, 10.2 ± 1.8 µm, and 6.8 ± 1.3 µm, respectively.

In non-white type intestinal lymphangiectasia with protein-losing enteropathy, a reticular network of thin dark branching bands was observed beneath the epithelium, and remarkably dilated unenhanced dark ducts deep in the mucosa, accompanied by fluorescence enhancement of lamina propria and numerous cell gaps ( [Fig. 7a--e](#FI685-7){ref-type="fig"} ).

![ Intestinal lymphangiectasia, non-white type with protein-losing enteropathy (Patient \#30). **a** Enteroscopic view with small round villi in the ileum. **b** A probe-based confocal laser endomicroscopic image on the surface of the villus with unenhanced lymphatic vessels. **c** A probe-based confocal laser endomicroscopic image deep in the mucosal layer with an unenhanced lymphatic duct. **d** Immunohistochemical staining with D2-40 antibodies in a biopsy specimen. Magnification × 200. **e** Immunohistochemical staining with D2-40 antibodies in a biopsy specimen. Magnification × 400.](10-1055-s-0043-106184-i685ei7){#FI685-7}

Preliminary comparison of the inner diameters of capillary vessels and lymphatic vessels between pCLE and histology
-------------------------------------------------------------------------------------------------------------------

In patients \#9, \#21, \#23, and \#30, the inner diameters of capillary vessels were 17.21 ± 3.21, 11.40 ± 4.19, 4.72 ± 2.67, and 7.47 ± 1.56 µm, respectively, in bioptic specimens immunostained with CD34, which were different from those both beneath the epithelium and in the middle of villi in pCLE images (24.2 ± 13.1 µm, *P*  = 0.01932, 13.5 ± 4.7 µm, *P*  = 0.1824, 14.2 ± 4.6 µm, *P*  \< 0.0001, 14.0 ± 3.2 µm, *P*  \< 0.0001). Both the inner diameters of capillary vessels beneath the epithelium and in the middle of villi were counted up in pCLE images because their distinction was difficult in specimens that were immunostained with CD34.

In patients \#9, \#21, \#23, and \#30, the inner diameters of lymphatic vessels were 15.1 ± 5.5, 24.7 ± 10.4, 10.2 ± 11.9, and 27.1 ± 17.0 µm, respectively, in bioptic specimens immunostained with D2-40, which were significantly different from those in pCLE images (6.8 ± 1.3 µm, *P*  = 0.0157, 4.8 ± 1.0 µm, *P*  = 0.0005, 10.2 ± 1.8 µm, *P*  = 0.5852, and 8.1 ± 1.5 µm, *P*  = 0.0005).

Epithelial and other pCLE findings
----------------------------------

In Peutz-Jeghers syndrome, a fluorescence-enhanced serrated homogenous epithelium was observed. In ischemic enteritis, numerous cell gaps were observed near the longitudinal ulcers and slightly dilated capillary vessels were frequently observed. Patients \#17 -- 19 with Crohn's disease showed numerous cell gaps and fluorescence enhancement of the lamina propria. In chronic nonspecific multiple small-intestinal ulcers unrelated to NSAIDs (CNSU), narrow, angulated, and partly stenosing capillary vessels of various sizes were observed accompanied by numerous cell gaps and fluorescence enhancement of the lamina propria. In hypogammaglobulinemia-associated atrophic enteritis with malabsorption syndrome, villous atrophy and the base of the crypts appeared as roundish glands resembling healthy colonic daisy crypts. In diclofenac-induced small-bowel injury, fluorescence enhancement of the lamina propria and numerous cell gaps were observed, while they were much less frequently observed in aspirin-induced small-bowel injury. In clonazepam-induced enteropathy with protein-losing enteropathy, villous atrophy and the base of the crypts appeared as roundish glands resembling colonic daisy crypts.

Comparison of pCLE findings with pathological diagnosis
-------------------------------------------------------

Of 35 pCLE examinations in 34 patients from whom biopsies, polypectomy, endoscopic mucosal resection, and surgical specimens were taken, pCLE findings in 32 (91 %) corresponded to pathologic diagnosis. The three inconsistent cases were patients \#7, \#32, and \#33. In patient \#7 with Burkitt lymphoma, complete remission was achieved by chemotherapy and no lymphoma cells were observed pathologically, but pCLE images showed homogenous tumor-like cells with dilated capillary vessels, which were presumably inflammatory cells caused by complicating cytomegalovirus infection. In patient \#32 with intestinal lymphangiectasia and with protein-losing enteropathy, lymphatic vessels were seldom observed with pCLE examination because they were predominantly subserosal lymphangiectasia type. In patient \#33 with Meckel's diverticulum, an aberrant gastric mucosa was observed pathologically, but was not observed with pCLE examination.

Adverse events
--------------

There were no complications associated with DBE, pCLE, and intravenous injection of fluorescein including bleeding, perforation, aspiration pneumonia, pancreatitis, and anaphylaxis.

Discussion
==========

As shown in the present study, CLE was able to visualize in detail the capillary and lymphatic vessels and the subsurface architecture of the mucosa in real time [@JR685-6] , which was not possible with ordinary formalin-fixed paraffin-embedded tissue sections. The present preliminary comparison between immunostaining with CD34 antibodies and pCLE suggested shrinkage of capillary vessels caused by the interruption of blood flow with endoscopic biopsy or resection. In comparisons between immunostaining with D2-40 antibodies and pCLE, however, histology showed that the inner diameters of the lymphatic vessels were larger than in the pCLE images, presumably because the lymphatic vessels were not shrunk immediately by the interruption of lymph flow, and/or because deep mucosal lymphatic vessels were being measured. Therefore, pCLE is a valuable tool for examining in vivo capillary and lymphatic changes in various pathologies.

In malignant lymphoma, aggressive lymphomas, such as diffuse large B cell lymphoma, showed larger irregular capillary vessels than indolent B cell lymphomas, such as follicular lymphoma. Metastasis from cervical cancer also showed this, as shown in [Fig. 4](#FI685-4){ref-type="fig"} . Santi et al. demonstrated that the microvascular calibers of resected specimens were significantly larger in submucosally invasive esophageal cancer than in intramucosal cancer [@JR685-7] . Deb et al. reported that histological grades of brain tumors positively correlated with microvessel calibers in surgical specimens [@JR685-8] . In tumors, irregular dilated capillary vessels may be indicative of the malignancy grade. We have also proposed a "soccer ball-like pattern" constituting homogenous dark cells packed with polygonal, slightly narrow and stretched capillary vessels, which was characterized by a pCLE image of a malignant lymphoma follicle. This characteristic pattern might be indicative of endoscopic assessment after treatment.

In vascular diseases, hereditary hemorrhagic telangiectasia (HHT) and solitary angiodysplasia showed numerous anastomoses of different calibers of capillary vessels. Meining et al. showed that the former version of pCLE detected a dilated sidled blood vessel with moving erythrocytes in real time, but not anastomosis due to poor resolution in gastric angiodysplasia [@JR685-9] . To our knowledge, this is the first study to demonstrate in vivo blood vessel anastomosis in intestinal vascular malformation. In small-bowel ulcers associated with IgA vasculitis, "a string of sausages" pattern characterized by segmental stenosis of capillary vessels was observed, possibly leading to ischemic changes. Patient \#13 was easily diagnosed as having IgA vasculitis because he had the complication of prior purpura in his legs. Abdominal symptoms, however, can precede the onset of the characteristic purpuric rash in 14 -- 36 % of patients [@JR685-10] . In such cases, pCLE may be useful for diagnosing vasculitis-associated ulceration because leukocytoclastic vasculitis is considered pathologically difficult to detect [@JR685-11] . Chronic non-specific multiple ulcers of the small intestine (CNSU) is a rare entity characterized by long-standing protein-losing enteropathy and iron-deficiency anemia from occult bleeding, reported chiefly in Japan, and recently published as an autosomal recessive inherited enteropathy caused by mutations in the SLCO2A1 gene, encoding a prostaglandin transporter [@JR685-12] [@JR685-13] [@JR685-14] [@JR685-15] . The present study found the distinctive angulated stenosis of capillary vessels beneath the epithelium of the villi and cell gaps (data not shown), which may lead to the pathogenesis of multiple ulceration and protein loss.

Another notable finding of the present study was in vivo visualization of lymphatic vessels in small-bowel pathology. In intestinal lymphangiectasia with protein-losing enteropathy, lymphatic blockage can occur at different sites, and lymphangiectasia can be present in the lamina propria only, whereas marked dilation of the lymphatics can occur in the subserosa and mesentery, with minimal changes in the lamina propria [@JR685-16] . We proposed a classification of intestinal lymphangiectasia into white villi type (the former lamina propria dominant type) and non-white villi type (the latter deeper layer dominant type) according to the enteroscopic findings, which clustered its manifestations and severity. Enteroscopically, the non-white villi type showed that apparently normal, but under more detailed observation, low and round villi with a normal color, were diffused [@JR685-17] . In two of three patients with non-white villi type intestinal lymphangiectasia, pCLE was able to detect lymphangiectasia, while detection did not occur in the remaining patient who was diagnosed only by autopsy, showing predominantly subserosal lymphangiectasia accompanied by marked fibrosis in the submucosal layer (data not shown). In all three patients, numerous cell gaps were also detected by pCLE, probably leading to protein-losing enteropathy.

In inflammatory diseases, including Crohn's disease and CNSU, interestingly, the inner diameters of capillary vessels beneath the epithelium were smaller. Kiesslich et al. found increased epithelial gaps and fluorescein leakage in the small intestine of patients with inflammatory bowel disease, which was associated with subsequent relapse [@JR685-18] . In this study, the same pCLE findings were observed depending on the enteroscopic findings. Narrowing of capillary vessels beneath the epithelial cells observed in this study might be ascribed to fluorescein leakage in the lamina propria and out of the epithelium.

Taken together, this in vivo histologic imaging has several clinical advantages over biopsy samples followed by a conventional pathology processes, including fixation, paraffin embedding, and staining steps: 1) to obtain live microscopic images, especially of capillary and lymphatic vessels, 2) to obtain real-time microscopic images of endoscopically ambiguous non-apparent lesions without time loss [@JR685-19] , 3) to obtain the functional properties including vascular permeability and cell shedding of fluorescence, 4) to benefit patients on antithrombotics, with bleeding tendencies, or with a condition for which taking pathological samples is contraindicated or not recommended, and 5) to obtain molecular imaging with administration of fluorescence-conjugated antibodies [@JR685-20] .

This study has some limitations, i. e. a small sample size and retrospective approach. Further larger-scale and prospective studies are needed to clarify the reliability of the above mentioned pCLE findings for diagnosing various small-bowel diseases. If our ongoing optical histologic findings are corroborated, it will help with rapid diagnosis and therapy selection. In conclusion, pCLE is safe and useful for the analysis of abnormalities of capillary and lymphatic vessels and the epithelium in various small-bowel diseases.
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